MG
NHS.RT

Marex Group’s Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) NHS.RT Stock Holding History

Marex Group’s Portfolio NHS.RT Stock Details NHS.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$450 Buy
+45,000
New +$392 ﹤0.01% 1003

Other funds holding NHS.RT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
UCI
Uncommon Cents Investing Janesville, Wisconsin $461M AUM 32.58% 1-Year Est. Return

Marex Group's NHS.RT Position: Q1 2026 in Review

Marex Group opened a new position in Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) (NHS.RT) in Q1 2026: 45,000 shares worth $450. The stake represents ﹤0.01% of the portfolio and ranks #1003 among its holdings.

43 funds tracked by Wall St. Rank hold NHS.RT as of Q1 2026.

  • Marex Group held 45,000 shares of Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) worth $450 as of Q1 2026.
  • Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) was a new Marex Group position in Q1 2026.
  • Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) made up ﹤0.01% of Marex Group's portfolio in Q1 2026, its #1003 holding.
  • 43 funds tracked by Wall St. Rank held Neuberger High Yield Strategies Fund Inc Rights (expiring April 15, 2026) as of Q1 2026.

Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.